Systemic Antifungals
High-yield Verified · Oct 2026Prototype: fluconazole
Systemic Antifungals are a class of medications used for invasive/systemic fungal infections.
The systemic counterparts to the topical antifungals — for invasive fungal disease, with much more serious toxicity.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 The target — the fungal membrane and wall
Fungal cells are protected by a membrane built around ergosterol (the fungal equivalent of the cholesterol in human membranes) and a cell wall made of glucan. Systemic antifungals attack these fungal-specific structures. Because human cells use cholesterol, not ergosterol, targeting ergosterol gives selectivity — but it isn’t perfect: amphotericin B also binds the cholesterol in human cell membranes, which is the source of its toxicity.
Three classes matter: azoles (fluconazole, voriconazole — the workhorses), polyenes (amphotericin B — the heavy hitter), and echinocandins (the -fungin drugs — relatively few adverse effects).
02 Amphotericin B — effective but “amphoterrible”
Amphotericin B is the broad, potent drug reserved for severe/life-threatening fungal infections — and it is notoriously toxic, nicknamed “amphoterrible.” Two toxicities dominate: infusion reactions (fever, chills/rigors, nausea — often premedicated with acetaminophen, antihistamine, ± meperidine for rigors) and nephrotoxicity with potassium and magnesium wasting (hypokalemia/hypomagnesemia). Slow infusion, hydration, electrolyte repletion, and lipid formulations (less nephrotoxic) reduce the harm.
The azoles are typically well tolerated but are CYP450 inhibitors — a major source of drug interactions (raising levels of statins, warfarin, and many others) — and can be hepatotoxic and prolong the QT. Echinocandins (-fungin) are IV-only with relatively few adverse effects (but can raise liver enzymes), used especially for invasive Candida.
Drug names
Indications
- Invasive/systemic fungal infections (candidemia, aspergillosis, cryptococcal meningitis, endemic mycoses)
- Serious mucosal candidiasis; antifungal prophylaxis in immunocompromised patients
- Amphotericin B for severe/refractory disease; echinocandins for invasive Candida
Mechanism of action
Azoles inhibit ergosterol synthesis (CYP-dependent 14-α-demethylase), disrupting the fungal membrane. Amphotericin B binds ergosterol, forming membrane pores that leak cell contents. Echinocandins inhibit β-(1,3)-glucan synthase, weakening the cell wall.
Therapeutic effects — what you'll see working
Success is clearing an invasive fungal infection. The nursing focus is amphotericin’s infusion/renal toxicity and the azoles’ drug interactions and liver/QT effects.
- Fungicidal/fungistatic effect
- Disrupting the fungal membrane or wall clears invasive infection over the treatment course.
Adverse effects
The profile depends on the class: amphotericin (infusion + renal/electrolyte, and rarely anaphylaxis), azoles (interactions, liver, QT), echinocandins (well tolerated).
Interactions
Contraindications
The labeled drug-combination bars shown here are fluconazole with QT-prolonging CYP3A4 drugs and voriconazole with strong enzyme inducers. The cautions are renal disease (amphotericin), the many other azole interactions, and pregnancy/QT.
Labs & levels
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Systemic Antifungals used for?
How do Systemic Antifungals work?
What are the serious side effects of Systemic Antifungals?
What labs should be monitored with Systemic Antifungals?
Conditions treated
"Itraconazole or posaconazole is recommended for antifungal prophylaxis in chronic granulomatous disease because studies have shown reduced rates of invasive fungal infections."
[Sjögren’s] "Antifungal therapies may be required when yeast infections develop" — thrush "more common in people with dry mouths."
Voriconazole is a listed SCC risk factor — note it in the history of a patient with new skin lesions.
Antifungal coverage — and an interaction. "some form of anti-fungal coverage" early after kidney transplant; but "azole antifungals such as voriconazole and posaconazole" markedly raise tacrolimus levels.
See also
The original β-lactams — bactericidal cell-wall inhibitors. The defining nursing job is screening for and recognizing allergy, from rash to anaphylaxis.
β-lactam cousins of penicillin, organized by generation — each generation trades some gram-positive reach for broader gram-negative coverage.
Powerful, broad-spectrum DNA-synthesis blockers — but a boxed warning for disabling tendon, nerve, and CNS effects means they’re reserved when alternatives exist.
Suppress viral replication rather than kill viruses outright. The nursing essentials: hydrate with acyclovir, start early (flu within 48 h), and remember most antivirals suppress — they don’t cure.
Powerful IV drugs for serious Gram-negative infection — but nephrotoxic and ototoxic. Levels matter.
Broad, generally safe protein-synthesis inhibitors — a penicillin-allergy alternative. Watch QT and CYP3A4.
Sources
- Amphotericin B — nephrotoxicity, infusion reactions, electrolyte wasting — StatPearls (NCBI)
- Fluconazole / azole antifungals — ergosterol synthesis, CYP interactions — StatPearls (NCBI)
- DIFLUCAN (fluconazole) — mechanism, indications, QT/CYP3A4 contraindications, teratogenicity (FDA label) — FDA / DailyMed
- VFEND (voriconazole) — QT, visual disturbances, interactions (FDA label) — FDA / DailyMed
- CANCIDAS (caspofungin) — echinocandin, glucan synthesis (FDA label) — FDA / DailyMed
- Amphotericin B for Injection (conventional) — boxed warning, mechanism, infusion (FDA label) — FDA / DailyMed
- Amphotericin B Liposome for Injection — less toxic than deoxycholate (FDA label) — FDA / DailyMed
- Antifungal Agents — azole tolerability, echinocandin role — StatPearls (NCBI)
- Caspofungin — mechanism, adverse effects — StatPearls (NCBI)
- Antifungal Ergosterol Synthesis Inhibitors — StatPearls (NCBI)
- Antifungal potential of auranofin — amphotericin "amphoterrible" (Int J Mol Sci 2025) — PMC (CC BY)
- Cardiovascular and Renal System — normal potassium range (Nursing Pharmacology) — Open RN (NCBI Bookshelf)
- Magnesium — normal serum range — StatPearls (NCBI)
- Creatinine Clearance — serum creatinine reference ranges — StatPearls (NCBI)
- Liver Function Tests — reference ranges — StatPearls (NCBI)
- The use of stems in the selection of International Nonproprietary Names (-conazole, -fungin) — World Health Organization
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.